BATS BZX Real-Time Price
As of 2:27pm ET
| +0.01 / +0.17%|
The 2 analysts offering 12-month price forecasts for Tetraphase Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 19.00 and a low estimate of 15.00. The median estimate represents a +195.65% increase from the last price of 5.75.
The current consensus among 6 polled investment analysts is to Buy stock in Tetraphase Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.